Business Description
Shanxi Jinbo Bio pharmaceutical Co Ltd
ISIN : CNE100006392
Compare
Compare
Traded in other countries / regions
832982.China IPO Date
2023-07-20Description
Shanxi Jinbo Bio pharmaceutical Co Ltd is engaged in research & development, production and sales of various medical devices and functional skin care products with recombinant collagen products and anti-HPV biological protein products as the core.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.39 | |||||
| Equity-to-Asset | 0.69 | |||||
| Debt-to-Equity | 0.23 | |||||
| Debt-to-EBITDA | 0.56 | |||||
| Interest Coverage | 39.22 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 22.52 | |||||
| Beneish M-Score | -2.15 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 67.4 | |||||
| 3-Year EBITDA Growth Rate | 79.5 | |||||
| 3-Year EPS without NRI Growth Rate | 97.5 | |||||
| 3-Year FCF Growth Rate | 30.6 | |||||
| 3-Year Book Growth Rate | 41.8 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.49 | |||||
| 9-Day RSI | 41.18 | |||||
| 14-Day RSI | 41.35 | |||||
| 6-1 Month Momentum % | -20.08 | |||||
| 12-1 Month Momentum % | 838.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | |||||
| Quick Ratio | 3.02 | |||||
| Cash Ratio | 2.3 | |||||
| Days Inventory | 286.41 | |||||
| Days Sales Outstanding | 47.92 | |||||
| Days Payable | 240.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.85 | |||||
| Dividend Payout Ratio | 0.09 | |||||
| Forward Dividend Yield % | 0.85 | |||||
| 5-Year Yield-on-Cost % | 0.85 | |||||
| 3-Year Average Share Buyback Ratio | -2.8 | |||||
| Shareholder Yield % | 0.46 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 90.64 | |||||
| Operating Margin % | 49.08 | |||||
| Net Margin % | 40.81 | |||||
| FCF Margin % | 26.67 | |||||
| ROE % | 46.06 | |||||
| ROA % | 28.76 | |||||
| ROIC % | 47.26 | |||||
| ROC (Joel Greenblatt) % | 69.41 | |||||
| ROCE % | 42.8 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 32.6 | |||||
| PE Ratio without NRI | 32.19 | |||||
| Shiller PE Ratio | 138.77 | |||||
| Price-to-Owner-Earnings | 45.09 | |||||
| PEG Ratio | 0.89 | |||||
| PS Ratio | 13.38 | |||||
| PB Ratio | 11.44 | |||||
| Price-to-Tangible-Book | 12.31 | |||||
| Price-to-Free-Cash-Flow | 50.46 | |||||
| Price-to-Operating-Cash-Flow | 30.29 | |||||
| EV-to-EBIT | 35.78 | |||||
| EV-to-EBITDA | 35.78 | |||||
| EV-to-Revenue | 17.5 | |||||
| EV-to-FCF | 65.64 | |||||
| Price-to-Projected-FCF | 10.75 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.6 | |||||
| Price-to-Graham-Number | 4.2 | |||||
| Price-to-Net-Current-Asset-Value | 34.43 | |||||
| Price-to-Net-Cash | 119.01 | |||||
| Earnings Yield (Greenblatt) % | 2.79 | |||||
| FCF Yield % | 1.49 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanxi Jinbo Bio pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 877.7 | ||
| EPS (TTM) (Â¥) | 5.44 | ||
| Beta | 2.06 | ||
| Volatility % | 430.33 | ||
| 14-Day RSI | 41.35 | ||
| 14-Day ATR (Â¥) | 8.070617 | ||
| 20-Day SMA (Â¥) | 180.561 | ||
| 12-1 Month Momentum % | 838.17 | ||
| 52-Week Range (Â¥) | 23 - 302.33 | ||
| Shares Outstanding (Mil) | 88.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanxi Jinbo Bio pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanxi Jinbo Bio pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shanxi Jinbo Bio pharmaceutical Co Ltd Frequently Asked Questions
What is Shanxi Jinbo Bio pharmaceutical Co Ltd(BJSE:832982)'s stock price today?
The current price of BJSE:832982 is ¥177.33. The 52 week high of BJSE:832982 is ¥302.33 and 52 week low is ¥23.00.
When is next earnings date of Shanxi Jinbo Bio pharmaceutical Co Ltd(BJSE:832982)?
The next earnings date of Shanxi Jinbo Bio pharmaceutical Co Ltd(BJSE:832982) is .
Does Shanxi Jinbo Bio pharmaceutical Co Ltd(BJSE:832982) pay dividends? If so, how much?
The Dividend Yield %  of Shanxi Jinbo Bio pharmaceutical Co Ltd(BJSE:832982) is 0.85% (As of Today), Highest Dividend Payout Ratio of Shanxi Jinbo Bio pharmaceutical Co Ltd(BJSE:832982) was 0.11. The lowest was 0.09. And the median was 0.11. The  Forward Dividend Yield % of Shanxi Jinbo Bio pharmaceutical Co Ltd(BJSE:832982) is 0.85%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers